Gilead Sciences, Inc [GILD] stock prices are down -1.77% to $104.08 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GILD shares have gain 8.37% over the last week, with a monthly amount glided 12.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gilead Sciences, Inc [NASDAQ: GILD] stock has seen the most recent analyst activity on February 13, 2025, when DZ Bank upgraded its rating to a Buy but kept the price target unchanged to $108 for it. Previously, Morgan Stanley upgraded its rating to Overweight on January 10, 2025, and elevated its price target to $113. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $110 on November 15, 2024. Citigroup initiated its recommendation with a Buy and recommended $125 as its price target on November 14, 2024. Maxim Group downgraded its rating to Hold for this stock on November 08, 2024. In a note dated October 21, 2024, Leerink Partners upgraded an Outperform rating on this stock and boosted its target price from $74 to $96.
The stock price of Gilead Sciences, Inc [GILD] has been fluctuating between $62.07 and $106.43 over the past year. Currently, Wall Street analysts expect the stock to reach $89.71 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $104.08 at the most recent close of the market. An investor can expect a potential drop of -13.81% based on the average GILD price forecast.
Analyzing the GILD fundamentals
The Gilead Sciences, Inc [NASDAQ:GILD] reported sales of 28.73B for trailing twelve months, representing a surge of 6.50%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.04 and Total Capital is 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 103.11 points at the first support level, and at 102.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 105.87, and for the 2nd resistance point, it is at 107.66.
Ratios To Look Out For
It’s worth pointing out that Gilead Sciences, Inc [NASDAQ:GILD]’s Current Ratio is 1.50. In addition, the Quick Ratio stands at 1.20. Considering the valuation of this stock, the price to sales ratio is 4.51, the price to book ratio is 6.74 and price to earnings (TTM) ratio is 280.61.
Transactions by insiders
Recent insider trading involved Dickinson Andrew D, Chief Financial Officer, that happened on Feb 12 ’25 when 0.14 million shares were sold. Officer, ANDREW DICKINSON completed a deal on Feb 12 ’25 to buy 0.14 million shares. Meanwhile, Chief Financial Officer Dickinson Andrew D sold 0.14 million shares on Jan 31 ’25.
